Гематология
1411 статей · 38 журналов
Динамика публикаций
Журналы подкатегории (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (89)
- Blood Advances · Elsevier (89)
- Journal of Thrombosis and Haemostasis · Elsevier (85)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (80)
- Thrombosis Research · Elsevier (80)
- British Journal of Haematology · Wiley (75)
- European Journal of Haematology · Wiley (74)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (71)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (66)
- Blood · Elsevier (65)
- Vox Sanguinis · Wiley (65)
- Annals of Oncology · Elsevier (62)
- American Journal of Hematology · Wiley (58)
- Haemophilia · Wiley (58)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion · Wiley (49)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- The Lancet Haematology · Elsevier (28)
- Seminars in Oncology · Elsevier (27)
- Experimental Hematology · Elsevier (21)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (14)
- Transfusion Medicine · Wiley (13)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (7)
- Leukemia · Springer Nature (7)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
- Letter to the editor regarding “Comparative validation of AHA/ACC 2026 and ESC 2019 risk stratification in hospitalized patients with acute pulmonary embolism” by Li Y et al
- Letter to the editor regarding the article “Comparing perioperative heparin bridging strategies in mechanical heart valve patients undergoing surgery: A systematic review and Bayesian meta-analysis”
- Reply to the letter: “From Apicat to Apicath?”
- Anticoagulation management and outcomes in cancer-associated gonadal and renal vein thrombosis: A multicenter retrospective cohort study
- From APICAT to APICath?
- Patient adherence and satisfaction with self-administration of prophylactic Low Molecular Weight Heparin (LMWH) after orthopaedic trauma surgery: a prospective observational cohort study.
- Limitations of protamine sulphate for in vitro neutralization of unfractionated heparin in thrombin generation assays
- Prospective pilot case series of off-label use of apixaban in patients with localized intravascular coagulopathy
- Portal and hepatic vein thrombosis in Philadelphia-negative myeloproliferative neoplasms: Insights from the National Inpatient Sample
- Abstracts from the CanVECTOR 2026 Annual Conference - November 6, 2026
- Evaluation of a standardized nursing workflow for the prevention of lower-limb deep vein thrombosis in patients with sepsis: A retrospective cohort study
- Association of autoimmune diseases and transient risk factors with clinical outcomes in patients with venous thromboembolism: COMMAND VTE registry insights
- Exploring therapeutic drug monitoring-guided direct oral anticoagulant use in patients with non-small cell lung cancer treated with small-molecule inhibitors
- Immunothrombosis: Molecular drivers, endothelial gatekeeping, and the failure of resolution
- Construction of animal models based on exploring pathological features and mechanisms of different locations in the progression of DVT-APTE-CTEPD/CTEPH
- Safety of home treatment for incidental pulmonary embolism in cancer patients
- Identification of clinical profiles in deep vein thrombosis through unsupervised clustering: an exploratory analysis
- A retrospective evaluation of clotting factor concentrate usage for the periprocedural management of patients with hemophilia A before and after the introduction of emicizumab
- Subacute thromboelastographic clot strength and discharge functional status after acute ischemic stroke
- Personalising AML treatment: beyond age and fitness
- Response-adapted inotuzumab ozogamicin in paediatric first-relapse B-cell acute lymphoblastic leukaemia
- Response-adapted inotuzumab ozogamicin in paediatric first-relapse B-cell acute lymphoblastic leukaemia – Authors' reply
- Rilzabrutinib, an oral Bruton tyrosine kinase inhibitor, in patients with warm autoimmune haemolytic anaemia: a prospective, single-arm, multicentre, phase 2b safety and clinical activity study (LUMINA 2)
- Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial
- Felzartamab plus lenalidomide–dexamethasone versus lenalidomide–dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial
- Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial
- High time for risk-adapted treatment in mantle cell lymphoma
- At the heart of unmet need: TP53 myeloid neoplasms
- Redefining plasma cell leukaemia
- When inflammation conceals malignancy in the urinary bladder